ArticleFrontiers in cell and developmental biology2025
Deep learning system for the auxiliary diagnosis of thyroid eye disease: evaluation of ocular inflammation, eyelid retraction, and eye movement disorder.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hyper-Thyro Vision: An Integrated Framework for Hyperthyroidism Diagnostic Facial Image Analysis Based on Deep Learning.Biomimetics (Basel, Switzerland) · 2026Article
- Diagnosis and treatment progress of upper eyelid abnormalities in thyroid-eye disease.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to construct a semantic segmentation-based auxiliary diagnostic model for thyroid eye disease (TED) focusing on eyelid retraction, eye movement disorders, ocular inflammation related to Clinical Activity Score (CAS), facilitating rapid and non-invasive diagnosis for suspected TED patients and enhancing the efficiency of treatment and diagnosis. Methods: Data were collected from 153 subjects exhibiting symptoms of eyelid retraction, eye movement disorders, and ocular inflammation related to CAS. After quality screening, datasets for the primary position (303 eyes), gaze positions (1,199 eyes), and a multi-label inflammatory classification dataset (272 eyes) were constructed. The constructed TBRM-Net adopts a dual-branch feature extraction and fusion strategy to extract inflammation features for multi-label classification and recognition; the constructed DSR-Net performs segmentation of ocular structures and has designed a quantitative diagnostic algorithm. Results: The semantic segmentation-based auxiliary diagnostic model for TED demonstrated a mean pixel accuracy (MPA) of 94.1% in the primary position dataset and 95.0% in the gaze positions dataset. The accuracy for diagnosing eye movement disorders, upper eyelid retraction, and lower eyelid retraction reached 85.4%, 95.1%, and 87.0%, respectively. The accuracy for Redness of Eyelids, Swelling of Eyelids, Redness of Conjunctiva, Swelling of Conjunctiva, and Swelling of Caruncle or Plica reaches 81.8%, 78.8%, 90.6%, 73.5%, and 83.9%, respectively, with an average accuracy of 81.7%. Segmenting and classifying images of structures affected by ocular inflammation can effectively exclude interfering features. The designed quantitative algorithm provides greater interpretability than existing studies, thereby validating the effectiveness of the diagnostic system. Conclusion: The deep learning-based auxiliary diagnostic model for TED established in this study exhibits high accuracy and interpretability in the diagnosis of ocular inflammation related to CAS, eyelid retraction, and eye movement disorders. It holds significant medical value in assisting doctors in formulating treatment plans and evaluating therapeutic effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.